Adhesive Patch Biotech Zosano Pharma, Inc. Postpones $70 Million IPO
8/27/2014 6:53:47 AM
Zosano Pharma, a biotech developing a transdermal delivery system to treat osteoporosis, postponed its IPO. The Fremont, CA-based company originally planned to raise $70 million by offering 6.4 million shares at a price range of $10 to $12. At the midpoint of the proposed range, it would have commanded a fully diluted market value of $139 million. The IPO market has largely shut down in August, meaning Zosano could attempt to go public in September if the biotech window remains open.
Help employers find you! Check out all the jobs and post your resume.
comments powered by